Suzetrigine (VX-548) is a potent, highly selective NaV1.8 inhibitor. It affects peripheral nociceptive signaling by blocking sodium ion influx through NaV1.8 channels in sensory neurons, inhibiting action potential propagation to effectively alleviate acute and chronic pain.